Mitochondrial import of a yeast cytoplasmic tRNALys: possible roles of aminoacylation and modified nucleosides in subcellular partitioning  by Entelis, Nina S. et al.
FEBS Letters 384 (1996) 38-42 FEBS 16873 
Mitochondrial import of a yeast cytoplasmic tRNA Lys" possible roles of 
aminoacylation and modified nucleosides in subcellular partitioning 
Nina S. Entelis ~,b,*, Igor A. Krasheninnikov b, Robert P. Martin ~, Ivan A. Tarassov ~,b 
a UPR 9005 du CNRS, "Mecanismes Moleculaires de Division Cellulaire et du Developpement', 15 rue Rene Descartes, 67084 Strasbourg, France 
b Division of Molecular Biology, Biology Faculty, Moscow State University, Moscow 119899, Russia 
Received 12 February 1996 
Lys Abstract The yeast tRNAcu U is transcribed from a nuclear 
gene and then unequally redistributed between the cytosol (97- 
98%) and mitochondria (2-3%). We have optimized the 
conditions for its specific import into isolated mitochondria. 
However, only a minor fraction (about 0.5%) of the added tRNA 
was translocated into the organelles. An in vitro transcript, once 
aminoacylated, appeared to be a better import substrate than the 
natural tRNA which carries modified nucleosides. The tRNA is 
translocated across mitochondrial membranes in its aminoacy- 
lated form and remains relatively stable inside the organelle. 
Possible roles of aminoacylation, tRNA-protein interactions and 
nucleoside modification in subcellular partitioning of the tRNA 
are discussed. 
Lys Key words: Mitochondrial import; tRNAcu U; 
Aminoacylation; ( Saccharomyces cerevisiae) 
1. Introduction 
Mitochondrial import of tRNA is now considered to be a 
widely spread process, having been reported in the yeast Sac- 
charomyces eerevisiae, in higher plants, in Tetrahymena nd in 
trypanosomatids (for a review, see [1]). Various sets of cyto- 
solic tRNAs are imported in different organisms; they range 
from a single tRNA in yeast [2,3] to the all of mitochondria- 
associated tRNAs in trypanosomatids [4,5]. The recent devel- 
opment of in vitro and in vivo tRNA import test systems 
provided irect evidence for the existence of a mitochondrial 
tRNA import pathway [6-10]. However, the mechanisms of
tRNA targeting and translocation across mitochondrial mem- 
branes remain largely unknown. To study these mechanisms, 
we have set up a specific in vitro import assay using isolated 
mitochondria of S. cerevisiae [7]. In this organism, a single 
Lys nuclear-coded tRNA, the tRNAcut: (tRK1) is in part asso- 
ciated with the mitochondrial matrix [2,3]. The mitochondrial 
concentration f tRK1 is comparable to that of minor native 
mitochondrial tRNAs. Yeast cells contain two other lysine 
isoacceptors, the nuclear-coded tRNALr.]~u, (tRK2) which is 
restricted to the cytosol and the mitochondrial DNA-coded 
tRNALYScmnm5vuv (tRK3) which is only found within mito- 
chondria. In our import assay, tRK1 is specifically taken up 
by isolated mitochondria n an energy- and membrane poten- 
tial-dependent manner, requiring the mitochondrial pre-pro- 
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tein translocation machinery, including a mitochondrial outer 
membrane receptor, MOM19, and an essential inner mem- 
brane translocation factor, MIM44 [11]. In addition, soluble 
cytoplasmic proteins are also required [7,8]. We have recently 
identified two of these factors as the cytoplasmic lysyl-tRNA 
synthetase (KRS) and the precursor of the mitochondrial ly- 
syl-tRNA synthetase (MSK) [12]. The main role of KRS ap- 
pears to be aminoacylation f tRK1, which is a prerequisite 
for its mitochondrial targeting. The precursor of MSK is also 
essential for the import process. Since MSK is able to form 
stable complexes with the aminoacylated form of tRK1, we 
favor the hypothesis of its carrier function for the tRNA [12]. 
Despite the high selectivity of the in vitro import reaction of 
tRK1, only a minor fraction of the tRNA added to the import 
mixture is in fact transported into the organelles. This con- 
trasts with the high efficiency of in vitro import of mitochon- 
drial pre-proteins [13]. On the other hand, in vivo tRK1 is 
unequally distributed between the cytosol and mitochondria, 
only 2-3% being associated with the mitochondrial matrix 
[2,3]. Such an unequal compartmentalization is ot unique 
for tRK1. The MRP RNA is mostly present in the nucleus, 
only a minor portion being associated with mitochondria [14]. 
Some proteins, for example, isoforms of tRNA modification 
enzymes, are also unequally distributed between different cel- 
lular compartments [15,16]. It is plausible that the reasons for 
unequal compartmentalization of tRK1 in vivo and for its low 
import efficiency in vitro might be similar. 
Here we attempted to increase the import efficiency of 
tRK1 by optimizing different parameters of the in vitro im- 
port reaction. Based on our results, we propose two possible 
mechanisms governing intracellular compartmentalization of 
tRK1. 
2. Materials and methods 
The S. cerevisiae strain YPH500 [17] was used for isolation of 
mitochondria s described elsewhere [7,11]. In some experiments 
(see section 3), mitochondria were preincubated with various amounts 
of E. coli 16S and 23S rRNA (Boheringer Mannheim) at 0°C for 10 
min and repelleted before the import assay. The in vitro import was 
directed by crude extracts (IDP) from hMOM19mv cells [18] carrying 
plasmid pG1 lfr6 [19] to overexpress in the cytoplasm the precursor 
form of MSK [12]. Immunodepletion f KRS was performed using 
anti-KRS antibodies (kindly provided by M. Mirande) as described 
previously [12]. To obtain an in vitro tRK1 transcript, he tRK1 gene 
(from plasmid pY109 kindly provided by H. Feldmann) was cloned 
using PCR under control of T7 promoter with a BstNI site at the 3'- 
terminus of the coding sequence. The resulting plasmid, ptRK1-T7, 
was BstNI-digested and transcribed using T7 RNA polymerase. Tran- 
scripts were gel-purified and subjected to heat denaturation followed 
by renaturation i the presence of 5 mM MgC12 and 1 mM spermi- 
dine. Aminoacylation was carried out with purified KRS (kindly pro- 
vided by M. Mirande) as described previously [12]. E. coli tRNA ehe 
was purchased from Boehringer Mannheim. Yeast tRNA A~p was an in 
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vitro transcript aminoacylated with purified yeast aspartyl-tRNA 
synthetase (both kindly provided by A. Wolfson). After aminoacyla- 
tion the enzyme was removed by phenol treatment. The standard 
import reaction (200 ktl) contained freshly isolated mitochondria 
(100 ~tg of mitochondrial protein), 3 pmol of (5'-a2P)-labelled tRNA 
and 5-150 ktg of IDP in 0.44 M mannitol, 20 mM HEPES-KOH (pH 
6.8), 20 mM KC1, 2.5 mM MgC12, 1 mM ATP, 5 mM dithiothreitol, 
0.5 mM phenylmethylsulfonyl fluoride, 0.1 mM diisopropyl f uoro- 
phosphate, 0.1 mM L-lysine, 0.5 mM phosphoenolpyruvate and 4 units 
of pyruvate kinase. The import was carried out at 25-30°C for 20 
min. Mitochondria were then treated with a mixture of RNases [3]. 
Mitoplasts were generated by hypotonic shock (10 mM HEPES- 
KOH, pH 6.8, l0 min at 0°C) and purified after addition of sorbitol 
to 0.44 M. Mitoplasts were lysed in 1% SDS, 0.1 M sodium acetate 
(pH 4.8) and 0.05% diethyl pyrocarbonate at 60°C and mitochondrial 
RNA was phenol-extracted at the same temperature. Imported 
tRNAs were analyzed by denaturing 15% polyacrylamide g l electro- 
phoresis and autoradiography. Quantitation of tRNA import was 
performed by scanning the gels in a Bio-Image Analyzer (Fuji). For 
import of [a4C]aminoacylated tRNAs, 1 ktg of tRNA was aminoacy- 
lated with [a4c]lysine or [14C]aspartic a id (Amersham, >200 mCi/ 
mmol) and 0.2 x xl06 cpm of labelled tRNA (trichloroacetic a id-pre- 
cipitable material) were taken for each import assay. Import of 
[14C]aminoacyl-tRNAs was measured as the label present in trichloro- 
acetic acid precipitates of total mitochondrial RNA. All the values are 
the average of three or four independent experiments. 
3. Results and discussion 
3.1. Optimization of the in vitro import reaction of tRK1 
Specific uptake of tRK1 by isolated mitochondria s energy- 
dependent and requires both the integrity of the mitochon- 
drial pre-protein translocation machinery and the presence 
of cytoplasmic soluble proteins [7,8,11]. We show here that 
the import efficiency of tRK1 depends upon the concentra- 
tions of tRK1 and IDPs in the import mixture and upon the 
presence of ATP, and varies as a function of pH and tem- 
perature (Fig. 1). Optimal import conditions (100 ~tg of mi- 
tochondrial proteins, 3 pmol tRK1, 50 ~tg of IDPs in 0.2 ml, 
1 mM ATP and the presence of an ATP regeneration system, 
pH 6.8, 25°C) yielded 0.05 pmol of imported tRK1 per mg of 
mitochondrial proteins (MP). This amount represents only 
0.16% of the tRK1 molecules added to the import assay. 
The in vivo mitochondrial content of tRK1 can be estimated 
to be around 2.5 pmol per mg MP ([2,3], I.A. Tarassov). This 
means that the efficiency of the in vitro import is only about 
2% of that in vivo. 
Quantitation of tRK1 degradation i  the import mixture 
and in repurified mitochondria [7] indicated egradation of 
about 20% of the added tRK1 after a 30 min incubation 
with all components of the assay. Therefore, the low amount 
of tRK1 detected within mitochondria cannot be explained 
solely by its degradation i the import mixture and/or inside 
the organelle. The efficiency of tRK1 import may, however, be 
decreased by non-specific binding of the tRNA to the mito- 
chondrial surface. In fact, isolated mitochondria bind tRK1 as 
well as E. coli tRNA phe (which is not imported) non-specifi- 
cally (Fig. 2A). Mitochondria-bound tRNA can be removed, 
although not entirely, by treatment of mitochondria with a 
mixture of RNases. In fact, total elimination of bound tRNA 
can only be achieved by removal of the outer mitochondrial 
membrane and RNAse treatment of the mitoplasts. The frac- 
tion of mitochondria-bound tRK1 may be inaccessible for 
import, which in turn would affect its import efficiency. To 
test this hypothesis, we performed competition experiments by 
adding non-labelled tRNAs to the import mixture (Fig. 2B). 
Import assays were conducted in the simultaneous presence of 
labelled tRK1 and of increasing amounts of non-labelled 
tRK1 or of E. coli tRNA Phe. A 10-fold excess of non-labelled 
tRK1 completely blocked the import of labelled tRK1, due to 
specific competition. In contrast, addition of increasing 
amounts of non-labelled tRNA Phe did not inhibit tRK1 im- 
port but rather had a slight enhancement effect (at 5-10 ~tg of 
competitor tRNA/mg MP). In order to neutralize the non- 
specific RNA-binding sites at the mitochondrial surface, we 
introduced a step of pre-incubation of mitochondria with 
E. coli rRNA prior to the tRK1 import reaction. As shown 
in Fig. 2C, rRNA-treated and repurified mitochondria were in 
fact more efficient in the import assay. Under optimal condi- 
tions, the import efficiency reached on average 0.1 pmol tRK1 
per mg MP. Nevertheless, this value corresponds to only 0.3% 
of the tRK1 added to the in vitro assay and to 4% of its in 
vivo mitochondrial pool. We are therefore forced to admit 
that the low in vitro tRK1 import efficiency must rely on 
reasons other than non-specific binding of the tRNA to mi- 
tochondria. 
As a possible mechanism leading to unequal distribution of 
tRK1 among the cytosol and mitochondria, we suggest that in 
the cytoplasm binding of tRK1 is subjected to competition 
between IDP and factors of the cytoplasmic translation appa- 
ratus. Indeed, our previous results indicate that aminoacyla- 
tion of tRK1 by the KRS (or, at least, formation of a tRK1- 
KRS complex) is required for its interaction with pre-MSK 
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Fig. 1. Optimization of tRK1 in vitro import conditions. Each assay 
was performed with the same amount of mitochondria correspond- 
ing to 100 ktg of mitochondrial protein. (A) Dependence of in vitro 
tRK1 import efficiency upon the amount of added tRK1. (B) Auto- 
radiographic detection of the imported tRK1 after electrophoretic 
separation of RNA extracted from repurified mitochondria. 'Pro- 
teins', amount of IDP; '-ATP', without ATP; '-ATP/gs', without 
ATP-generation system. 
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and, in turn, for its translocation across mitochondrial mem- 
branes [12]. Formation of ternary complexes which include 
tRK1, KRS and pre-MSK may reflect an intermediate step 
leading to the mitochondrial targeting of tRK1 [12]. We there- 
fore suggest that the competitive binding of tRK1-KRS com- 
plexes by either pre-MSK (alone or in association with other 
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Fig. 2. (A) Effect of non-specific binding of tRNA to mitochondria. 'Mitoplasts+RNAse 1' and 'Mitoplasts+RNAse 2' differed in the duration 
of RNase treatment after mitoplast isolation (10 and 20 min, respectively); 'Lysate+RNAse', after the import assay mitochondria were lysed 
with 0.5% Triton X-100 in the presence of RNAses. (B) Competition effect of non-labelled tRNAs onto tRK1 in vitro import. '+tRKI°-> ' and 
'+tRNAPhe-> ', addition of increasing amounts of non-labelled tRK1 and E. coli tRNA Phe, respectively (lag competitor tRNA per mg MP). 
(C) Effect of pretreatment of mitochondria with non-labelled E. coli ribosomal RNAs. Autoradiographic detection of the imported tRK1 ('C', 
32p-labelled tRK1 using in the import assay) and dependence of the relative tRK1 import efficiency upon rRNA concentration. 
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IDP) or cytoplasmic translation factors might be an essential 
step in the intracellular partitioning of tRK1. Such a hypoth- 
esis is in agreement with the fact that in the cytoplasm of 
higher eucaryotes, tRNAs (either deacylated or aminoacy- 
lated) are tightly integrated in RNA-protein interactions of 
the protein synthesis pathway ('channelled tRNA cycle'), 
which implies that no 'free' tRNAs exist in the cytosol [20,21]. 
3.2. An in vitro transcript of the tRK1 gene is a better import 
substrate than the natural tRNA 
An alternative xplanation for unequal compartmentaliza- 
tion of tRK1 would be the existence of a minor subpopulation 
of 'import-active' tRNA molecules differing from 'import-in- 
active' molecules by structural features. All the eight chromo- 
somal tRK1 gene copies we have identified in strain YPH499, 
have identical coding sequences (I.A. Tarassov, unpublished). 
It is therefore not plausible that import-active and import- 
inactive tRK1 molecules differ by their primary sequence. 
However, it is not known whether mitochondrial and cyto- 
plasmic pools of tRK1 differ in the nature or extent of nucleo- 
side modification [3,22]. This opens the possibility that some 
specific nucleoside modification (or its absence) could play a 
role as an import discriminator. To investigate this possibility 
we compared the mitochondrial import efficiency of an in 
vitro-synthesized tRK1 transcript (which is expected not to 
carry modified nucleosides) with that of the natural fully mod- 
ified tRK1, Taking into account hat aminoacylation of tRK1 
is a prerequisite for its mitochondrial import [12], we tested 
the import of the in vitro transcript and of the natural tRNA 
in their deacylated forms and after aminoacylation with KRS 
prior to the import. The dependence of import efficiencies 
upon the concentration of IDP is shown in Fig, 3. The de- 
acylated transcript proved to be a poor import substrate, 
while the aminoacylated transcript showed a higher import 
efficiency than both the deacylated and aminoacylated forms 
of natural tRK1. The poor import efficiency of the deacylated 
transcript can be explained by its low level of aminoacylation 
during the incubation in import mixture. Indeed, the ratio 
between the KcatlKm values of aminoacylation reaction with 
KRS for tRK1 and for the in vitro transcript was found to be 
16,7. The aminoacylated transcript is imported with maximal 
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Fig. 3. Dependence of import efficiency upon IDP concentration. 
'T7-tr.RKI', in vitro T7-transcript of the tRK1 gene; 'lys-', RNA 
was aminoacylated prior to the import assay, then KRS was re- 
moved by phenol treatment; IDP immuno-depleted with anti-KRS 
antibodies [12] were used in import assay. 
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Fig. 4. In vitro import of [I4C]aminoacyl-tRNAs. y-axis values cor- 
respond to 14C label associated with mitochondrial tRNA as a func- 
tion of time (x-axis values) of incubation of mitochondria with the 
[14C]aminoaeyl-tRNAs. tRNA-Asp was an in vitro synthetized tran- 
script of the yeast RNA ASp gene. 
efficiency of 0.154).2 pmol per mg MP, which corresponds to 
0.454).6% of the transcript added to the in vitro assay (i.e., 6- 
8% of the in vivo mitochondrial pool of tRK1). Taken to- 
gether, these results indicate that modified nucleosides are not 
necessary for recognition of tRK1 by import factors but do 
not eliminate the possibility that some specific nucleoside 
modification(s) have a role of import discriminator(s). Alter- 
natively, hypomodification f tRK1 could lead to greater flex- 
ibility of the tRNA structure [23,24] which, in turn, could 
facilitate its transmembrane transfer. 
3.3. tRK1 is imported in its aminoacylated form which remains 
relatively stable within mitochondria 
As already stressed, aminoacylation f tRK1 by KRS (or at 
least formation of a tRK1-KRS complex) is a prerequisite for 
its mitochondrial targeting [12]. This opens the possibility that 
the tRNA might be imported in its aminoacylated form. To 
provide direct evidence for this hypothesis, we studied the fate 
of [14C]lysyl-tRK1 during the course of its import into iso- 
lated mitochondria (Fig. 4). As controls, the behaviour of 
aminoacylated tRK2 and of an aminoacylated tRNA Asp tran- 
script, both of which are not imported, has also been studied. 
With these two tRNAs, as expected, no trichloroacetic acid- 
precipitable 14C label was detected in mitochondrial RNA. In 
contrast, when aminoacylated tRK1 was used, increasing 
amounts of 14C label were found in mitochondrial RNA, at 
least during the first 30 min of the import reaction. This result 
clearly shows that tRK1 is translocated across mitochondrial 
membranes in its aminoacylated form. The amount of 
[14C]lysyl-tRK1 detected in mitochondrial RNA after a 30 
rain import reaction corresponds to 0.24).3% of the amino- 
acylated tRNA added to the reaction, which is very similar to 
the value obtained using 32p end-labelled tRK1 (see above). 
The fact that the mitochondrial pool of aminoacylated 
tRK1 was maximal after 30 min incubation (see Fig. 4) is 
consistent with our previous results showing that the in vitro 
import system is saturated within this period [7]. Since this 
amount only slightly decreased uring the following 30 min, 
the aminoacylated form of tRK1 is relatively stable within 
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mitochondria, at least in vitro. The fact that tRK1 enters 
mitochondria in its aminoacylated form and remains amino- 
acylated, at least for some time, within the organeUe, might be 
relevant o its mitochondrial function, possibly indicative of 
an involvement in mitochondrial protein synthesis. 
4. Conclusion 
Taken together, our results show that only a small fraction 
of the cytoplasmic tRK1 is translocated into mitochondria 
and suggest wo possible mechanisms leading to its unequal 
intracellular distribution. The first one supposes the existence 
of only a minor fraction of hypomodified tRK1 competent for 
import. The second one proposes that intracellular partition- 
ing of tRK1 results from competition between IDP and other 
proteins (most probably cytosolic translation factors) for 
binding to the aminoacylated tRNA. To distinguish between 
these two possible mechanisms, characterization of new IDP 
and mechanisms of their interactions with tRK1 and KRS, as 
well as identification of 'import determinants' within the 
tRK1 sequence will be helpful. 
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